(Q35008633)

5 August 2017

title

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody (English)

1 reference

5 August 2017

10

M E Lippman

1 reference

5 August 2017

H J Hnatyszyn

1

1 reference

5 August 2017

M Liu

2

1 reference

5 August 2017

A Hilger

3

1 reference

5 August 2017

L Herbert

4

1 reference

5 August 2017

C R Gomez-Fernandez

5

1 reference

5 August 2017

M Jorda

6

1 reference

5 August 2017

D Thomas

7

1 reference

5 August 2017

J M Rae

8

1 reference

5 August 2017

D El-Ashry

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

20 October 2009

1 reference

Breast Cancer Research and Treatment

5 August 2017

published in

1 reference

5 August 2017

volume

122

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

371-380

1 reference

Tamoxifen: a most unlikely pioneering medicine

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

GREB 1 is a critical regulator of hormone dependent breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0584-X

10.1007/S10549-009-0584-X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference